Oil spill and Omega Protein
This article was originally published in The Tan Sheet
The oil leak in the Gulf of Mexico following the explosion of the Deepwater Horizon rig forces Omega Protein to shift fishing operations away from its Moss Point, Miss., facility. CEO Joe von Rosenberg said May 10 he does not expect a negative affect on fish catch or product quality. On May 6, Omega Protein reported a 7 percent increase in revenue to $32.3 million in the first-quarter. Higher fish meal pricing was offset by decreased fish oil pricing, reflecting contracts initiated in 2008, the peak of the fish oil sales market, the omega-3 ingredient firm said. Net income during the three months ended March 31 dropped 53.4 percent to $979,000. The year-ago quarter included $2.7 million from a hurricane assistance grant
You may also be interested in...
The European Medicines Agency says that Shionogi’s novel antibiotic, Fetcroja, should be approved for use across Europe but that Lilly's migraine drug, Emgality, should not be authorized for the extended indication of episodic cluster headache.
Despite the life sciences industry’s call for continued alignment of medicines regulation with the EU from next year and for some sort of co-operation with the European Medicines Agency, it seems the UK government is prepared to make only small concessions.
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.